About Meidrix
Meidrix is a Healthcare company based in Esslingen Am Neckar (Germany) founded in 2009. Collagen-based implants for cartilage defect regeneration are developed. Meidrix has raised $1 million across 2 funding rounds from investors including Esslingen, Cascara Ventures and High-Tech Gründerfonds. Its chief executive, as recorded, is Michaela Noll. Meidrix offers products and services including ChondroFiller liquid. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is meidrix biomedicals GmbH.
Company details
Founded in 2009 in Esslingen am Neckar, Germany, collagen-based implants for soft tissue regeneration are developed in the biomedicine sector. Cell-free medical devices are provided to treat focal defects of articular cartilage in knees, ankles, and shoulder joints. A stable matrix form is employed, enabling minimally invasive surgical procedures. ChondroFiller gel is included among the products for addressing articular cartilage defects.
- Headquarters Esslingen Am Neckar, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website meidrix.de
- Social LinkedIn YouTube
- Legal Name Meidrix Biomedicals Gmbh
- Total Equity Funding$1M (USD)
in 2 rounds
- InvestorsEsslingen
& 2 more
Products & Services of Meidrix
Meidrix offers a comprehensive portfolio of products and services, including ChondroFiller liquid.
Implant for treating joint cartilage defects up to 3 cm² regeneratively.
Apps and channels of Meidrix
its YouTube channel meidrix biomedicals GmbH has 333 subscribers and 6 videos.
Videos from Meidrix
The most watched videos on Meidrix's YouTube channel, meidrix biomedicals GmbH (333 subscribers). Click a video to play it here.
More on meidrix biomedicals GmbH.
Funding Insights of Meidrix
Meidrix has successfully raised a total of $1M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1M
- Total Rounds 2
- First Round $1M
(Jan 2010)
- Investors Count 3
All 2 funding rounds of Meidrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2011 | Series A | – | Cascara Ventures | – | |
| Jan 2010 | $1M | Seed | – | HTGF, Esslingen | – |
3 investors in total: 3 institutional.
Investors in Meidrix
Meidrix has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Esslingen, Cascara Ventures and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are provided by Cascara Ventures in life sciences. | 2016 | cascaraventures.com | ||
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
Healthcare information is provided for the city area by Esslingen. | esslingen.de | Esslingen Am Neckar, Germany |
Investor details for Meidrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Meidrix
2 people are tracked at Meidrix (2 in leadership).
| Name | Role | Group |
|---|---|---|
Yi Sun | Managing Director | Leadership |
Michaela Noll | CEO & MD | Leadership |
Complete people profiles for Meidrix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Meidrix
3 dated milestones of Meidrix across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Meidrix is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series A,.
Web traffic of Meidrix
The website of Meidrix (meidrix.de) receives about 6.9K visits a month.
- Monthly visits6.9K
▼ 47.1% vs previous month
Websites whose visitors overlap most with Meidrix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
aca-cell.com | aca-cell.com | 100% | – | ||
| gerbu.de | 98% | #4,209,132 | View details | ||
brain-biotech-group.com | brain-biotech-group.com | 97% | – | ||
| molecularhealth.com | 96% | View details | |||
| veraxa.com | 96% | 4.2K | #4,458,181 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Meidrix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Meidrix
Meidrix was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Meidrix is headquartered in Esslingen Am Neckar, Germany. It is registered at Esslingen Am Neckar, Baden-wurttemberg, Germany.
Michaela Noll is the CEO of Meidrix, as recorded in our data.
Meidrix is a funded company, having raised a total of $1M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Jan 2010.
Founded in 2009 in Esslingen am Neckar, Germany, collagen-based implants for soft tissue regeneration are developed in the biomedicine sector. Cell-free medical devices are provided to treat focal defects of articular cartilage in knees, ankles, and shoulder joints. A stable matrix form is employed, enabling minimally invasive surgical procedures. ChondroFiller gel is included among the products for addressing articular cartilage defects.
Meidrix offers ChondroFiller liquid.
Meidrix has 3 investors. Key investors include Esslingen, Cascara Ventures, and High-Tech Gründerfonds.
Meidrix operates through Meidrix Biomedicals Gmbh.